From Margins to Mainstream: Key Milestones & Metrics in Psychedelic Clinical Research, Significance of the Recent FDA Guidance, & Outlooks for the Near Future

Time: 11:15 am
day: Conference Day One


  • A review of the key milestones and metrics in psychedelic clinical trials from past to present.
  • Highlights from the recent FDA draft guidance
  • Surveying the landscape for future trials and approvals